The present invention relates to the novel isolated 12–30 strain of Pestalotiopsis microspora capable of producing novel antioxidant and antimycotic agents. The present invention also relates to the novel isolated 3,5,7 trisubstituted isobenzofuranone and derivatives thereof, methods of isolating the novel isobenzofuranone from cultures P. microspora 12–30, and to novel uses of the compound as an antioxidant and antimycotic agent. The present invention further relates to a novel 1,5,7 trisubstituted 1,3-dihydroisobenzofuran and derivatives thereof, methods of isolating this novel compound from cultures of Pestalotiopsis microspora 12–30, and to uses thereof.
1. A biologically pure compound having the formula:
2. A biologically pure compound having the formula:
3. A pharmaceutical composition comprising the compound according to claim 1 and a pharmaceutically acceptable carrier.
4. A pharmaceutical composition comprising the compound according to claim 2 and a pharmaceutically acceptable carrier.
5. A method of producing isopestacin comprising:
a. growing the culture in culture medium under conditions wherein the compound according to claim 1 is made; and
b. isolating the compound from culture medium.
6. A method of producing pestacin comprising:
a. growing the culture in culture medium under conditions wherein the compound according to claim 2 is made; and
b. isolating the compound from culture medium.
7. A method of reducing free radicals in an organism comprising administering the compound of claim 1 or 2 to said organism.
8. A method according to claim 7 wherein said organism is a human.
9. A method of inhibiting the proliferation of a fungus comprising contacting said fungus with a compound according to claim 1 or 2 .